BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. 2005

Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
Biochemistry Laboratory, Faculty of Pharmacy, University of Oporto, 4050-047 Oporto, Portugal.

Inhibition of aromatase is an efficient approach for the prevention and treatment of breast cancer. New A,D-ring modified steroid analogues of formestane and testolactone were designed and synthesized and their biochemical activity was investigated in vitro in an attempt to find new aromatase inhibitors and to gain insight into their structure-activity relationships (SAR). All compounds tested were less active than formestane. However, the 3-deoxy steroidal olefin 3a and its epoxide derivative 4a proved to be strong competitive aromatase inhibitors (K(i) = 50 and 38 nM and IC50 = 225 and 145 nM, respectively). According to our findings, the C-3 carbonyl group is not essential for anti-aromatase activity, but 5alpha-stereochemistry and some planarity in the steroidal framework is required. Furthermore, modification of the steroidal cyclopentanone D-ring, by construction of a delta-lactone six-membered ring, decreases the inhibitory potency. From the results obtained, it may be concluded that the binding pocket of the active site of aromatase requires planarity in the region of the steroid A,B-rings and the D-ring structure is critical for the binding.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000731 Androstanes The family of steroids from which the androgens are derived.
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
April 2012, Journal of medicinal chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
Design, synthesis, biological activity evaluation and structure-activity relationships of new steroidal aromatase inhibitors. The case of C-ring and 7β substituted steroids.
February 2023, Bioorganic chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
October 2013, Journal of medicinal chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
July 2010, Journal of medicinal chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships.
October 2019, Bioorganic chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
Synthesis, structure-activity relationships and biological activity of new isatin derivatives as tyrosinase inhibitors.
January 2014, Current topics in medicinal chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
February 2008, Bioorganic & medicinal chemistry,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
New D-modified androstane derivatives as aromatase inhibitors.
August 2001, Steroids,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
A-ring bridged steroids as potent inhibitors of aromatase.
March 1993, The Journal of steroid biochemistry and molecular biology,
Margarida M D S Cepa, and Elisiário J Tavares da Silva, and Georgina Correia-da-Silva, and Fernanda M F Roleira, and Natércia A A Teixeira
A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.
October 2018, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!